GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (WBO:HSIC) » Definitions » Institutional Ownership

Henry Schein (WBO:HSIC) Institutional Ownership : 70.94% (As of May. 01, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Henry Schein Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Henry Schein's institutional ownership is 70.94%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Henry Schein's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Henry Schein's Float Percentage Of Total Shares Outstanding is 86.90%.


Henry Schein Institutional Ownership Historical Data

The historical data trend for Henry Schein's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henry Schein Institutional Ownership Chart

Henry Schein Historical Data

The historical data trend for Henry Schein can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 70.32 70.61 70.26 70.60 72.79 72.43 72.19 72.28 71.84 70.94

Henry Schein Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Henry Schein Business Description

Address
135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.